AI in the Clinic: Where We Are and Where We'r...

Retina is producing Phase 3 results faster than ever, but FDA approval doesn't necessarily convey how a drug will fit into practice. Dr. Ehsan Rahimy joins host Dr. Jay Sridhar to unpack recent and somewhat puzzling trial results involving tyrosine kinase inhibitors, IL-6 inhibit ...  Show more

What's a mom-to-be to do if she's also an ophthalmologist? In part 2 of this two-part series, host Dr. Ben Young invites Dr. Fei Cai, a maternal-fetal medicine specialist and obstetrician, to review the essentials of pre- and postnatal care, what to be mindful of if practicing wh ...  Show more

In this episode we speak with Quresh Mohamed, a Consultant Ophthalmologist from Cheltenham. We discuss his paper entitled, 'Post-injection endophthalmitis rates with reduced povidone-iodine prophylaxis in patients with self-reported iodine sensitivity'.

Join Dr Peters for an update in approaches to managing microvascular complications. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/933885?src=mkm_podcast_addon_933885 

In this episode with speak with Bhavin Shah, an Optometrist from North London with a special interest in myopia management. He provides an overview of the literature regarding existing and future treatments and provides a personal insight into how he manages patients in whom p ...